Roadshow
ThergiSpray
Thergispray is a single-dose, liquid-based, thermosensitive sprayable post-surgical anti-adhesion hydrogel that effectively solves the issues associated with existing products on the market.
This product is protected by granted patent families in the US, Japan, China, Taiwan, and the EU, covering both the polymer and its formulation.
Preclinical studies in rabbit and porcine models have demonstrated strong safety and efficacy profiles.
Results have been peer-reviewed and published in the International Journal of Biological Macromolecules (2025).
This product is suitable for both conventional and minimally invasive surgeries, and offers advantages including low cost, no time-consuming preparation, and easy assembly and use. The product utilizes a patented platform technology of chemically-modified polymers and can be applied as either a gel or spray, providing medical professionals and patients with a convenient and economical option.
- Established 2012
- Company PROVIEW-MBD BIOTECH CO., LTD.
- Telephone +886 03-5506-233#823
- Email ericaku@proview-biotech.com.tw
- Address 6 F.-1, No. 341, Sec. 4, Xinyi Rd., Da’an Dist., Taipei City 106068, Taiwan (R.O.C.)
Proview-MBD Biotech operates across a comprehensive spectrum of medical device development and manufacturing capabilities. Our core strength lies in research and development, with a focus on hydrogel-based medical device innovation and formulation optimization. This expertise extends into product manufacturing, covering Class I–III medical devices while maintaining strict GMP compliance.
Additionally, Proview-MBD Biotech possesses specialized expertise in regulatory affairs, managing medical device registration and ensuring regulatory compliance under TFDA jurisdiction. Quality assurance is a cornerstone of our operations, supported by the implementation of the ISO 13485 quality management system. Our specialized focus on post-surgical solutions emphasizes applications in adhesion prevention.